Soar­ing De­ci­phera cap­i­tal­izes on pos­i­tive tri­al with $400M of­fer­ing; Spring­Work hires ex-For­est Labs CFO

→ Af­ter post­ing the re­sults of a suc­cess­ful late-stage study test­ing its can­cer drug, lit­tle De­ci­phera Phar­ma­ceu­ti­cals $DCPH is rais­ing gross pro­ceeds of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA